Phosphate Lowering in CKD Trial

NCT02209636 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

66

Enrollment

FED

Sponsor class

Conditions

Chronic Kidney Disease
Cardiovascular Disease

Interventions

DRUG: Lanthanum carbonate
DRUG: placebo
DRUG: Ascorbic Acid
DRUG: Nitroglycerin
PROCEDURE: Flow-mediated dilation measurement
PROCEDURE: Aortic pulse-wave velocity
PROCEDURE: Endothelial cell collection

Sponsor

VA Office of Research and Development